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Abstract
Rodent studies have proposed that adolescent susceptibility to substance use is at least partly due to adolescents experiencing
reduced aversive effects of drugs compared to adults. We thus investigated methamphetamine (meth) conditioned place
preference/aversion (CPP/CPA) in adolescent and adult mice in both sexes using a high dose of meth (3 mg/kg) or saline as
controls. Mice tagged with green-fluorescent protein (GFP) at Drd1a or Drd2 were used so that dopamine receptor 1 (D1) and 2
(D2) expression within the insular cortex (insula) could be quantified. There are sex differences in how the density of D1+ and
D2+ cells in the insula changes across adolescence that may be related to drug-seeking behaviors. Immunohistochemistry
followed by stereology were used to quantify the density of cells with c-Fos and/or GFP in the insula. Unexpectedly, mice
showed huge variability in behaviors including CPA, CPP, or no preference or aversion. Females were less likely to show CPP
compared to males, but no age differences in behavior were observed. Conditioning with meth increased the number of D2 +
cells co-labelled with c-Fos in adults but not in adolescents. D1:D2 ratio also sex- and age-dependently changed due to meth
compared to saline. These findings suggest that reduced aversion to meth is unlikely an explanation for adolescent vulnerability
to meth use. Sex- and age-specific expressions of insula D1 and D2 are changed bymeth injections, which has implications for
subsequent meth use.
Related Objects: Dataset - https://doi.org/10.5281/zenodo.4983499
Key words: Adolescence; Dopamine; Insula; Methamphetamine; Sex differences
Abbreviations: ANOVA, analysis of variance; CPA, conditioned place aversion; CPP, conditioned place preference; D1, dopamine
receptor 1; D2, dopamine receptor 2; GENSAT, Gene Expression Nervous System Atlas; GFP, green fluorescent protein; i.p,. in-
traperitoneal; meth, methamphetamine; NDS, normal donkey serum; P, postnatal day; PB, phosphate buffer; PBS, phosphate
buffered saline; PFA, paraformaldehyde; RM, repeated measures; SD, standard deviations
1. Introduction
Methamphetamine (meth) is a highly addictive amphetamine-
type psychostimulant that is the second most commonly used il-
licit drug in the world [1]. Youth use is a major concern [1-3]. For
example, over 5% of Australians aged 14-19 have reported using
methamphetamine in the last 12 months [4]. Compared to other
addictive substances, prevalence of meth use in males is not al-
wayshigher than females [5-8], and femalesbeginusingmethear-
lier and transition more rapidly from initial to problematic meth
use [9-13]. These observations indicate that both age and sex are
important factors in meth use disorder. However, sex- and age-
dependent effects ofmeth on brain and behavior are poorly under-
stood.
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Addictive substances have not only rewarding but also aversive
properties, and it has been proposed that adolescent susceptibil-
ity to drug use is due to their reduced aversive experience to sub-
stances [14]. Rodent evidence suggests that adolescents are less
sensitive than adults to the aversive effects of amphetamine, co-
caine, nicotine, and ethanol [15-19], a finding that may extend to
meth. Conditioned place preference or aversion (CPP or CPA) is
widely used to study the preference or aversion to substances in ro-
dents [20-22]. The procedures for these paradigms are essentially
identical, with subjects learning to associate environmental cues
with a drug experience by receiving drug in one distinct chamber
and saline in another distinct chamber. When given unrestricted
access to both chambers without any drug, CPP is operationalised
as a significantly greater amount of time spent in the drug-paired,
compared to the saline-paired, context. In contrast, CPA is oper-
ationalised as spending significantly less time in the drug-paired,
compared to saline-paired, context.
Our aim was to assess potential CPA or CPP using a high dose
ofmeth in adolescent and adultmale and femalemice, and then to
examine dopamine receptors 1 (D1) and 2 (D2) expression in the
insular cortex (commonly referred to as insula). How these recep-
tors are involved inmethCPA (orCPP) arepoorlyunderstood, espe-
cially in the context of adolescence. D1 and D2 expression changes
throughout development in rodents and humans [23-25], which
has consequences on local excitatory and inhibitory control [26].
Differences between adults and adolescents in D1 and D2 expres-
sion in cortical regions have been proposed to explain adolescent
vulnerability to mental disorders, including in substance use dis-
orders [27]. Our recent comprehensive stereological investigation
showed that of many cortical regions, the insula showed the most
dramatic changes in D1 and D2 expression across adolescence in
male and female mice [28, for data see 29-36]. Specifically, fe-
males show D1 dominance in adolescence to adulthood, whereas
males show D1 and D2 balance in adolescence that changes to D1
dominance in adulthood [28]. ActivationofD1 stimulates,whereas
D2 inhibits adenylyl cyclase [37]. D1 agonist has been shown to in-
duce CPA, whereas D2 agonist has been shown to induce CPP in
adult male rats [38, 39]. D1 and D2 antagonists have been shown
to block amphetamine-inducedCPP in adultmale rats [40]. Taken
together, D2 appears necessary and sufficient for amphetamine-
induced CPP, while D1 may be important for CPA and CPP. Inter-
estingly, injection of the partial D2 antagonist olanzapine in ado-
lescence can enhance amphetamine-induced CPP in adulthood,
which was associated with reduced D1 and increased D2 binding
[41]. Insula activation has been shown to be critical for long-term
memory of CPP [42]. Based on previous findings on the necessity
of D1 signaling in CPA, we hypothesized that the lack of D1 domi-
nance in the insula of male adolescents may lead to reduced meth
CPA compared to females andmale adults.
Taken together, potential age and sex differences in meth
CPA/CPP, and related activation of cells expressing D1 and D2
within the insular cortexwere investigated in this studyusing vali-
dated transgenicmice expressing greenfluorescent protein (GFP)-
tagged D1 or D2 [43]. Postnatal day (P) 49 and P70mice were used
in this study because the biggest sex differences in insula D1 and
D2 expression were observed at P49 [28]. In fact, latest rodent
hormonal and cognitive development studies state that P49 cor-
responds to mid adolescence [44], which is appropriate given the
pattern of meth use in humans that begin first in mid to late ado-
lescence [3, 45]. In female mice, ovulation and vaginal opening
are not correlated, with first ovulation at ~P42 [46] and regular es-
trous cycling typically not observed until P60 [47]. In swiss mice
used in this study, P30 is considered pre-pubertal [48], with first
estrus cycle observed 10 days (i.e., P40) after vaginal opening [49].
Inmalemice, average ageofprepuce-glans separation is~P36 [50].
Thus, ‘adolescent’ will refer to mid adolescent P49 mice in this
study. To minimize the maturation that occurs during CPA/CPP,
we used a previously published 4-day conditioning protocol that
involved a saline injection eachmorning and ameth injection each
afternoon [51, 52], which is considerably shorter than a typical
CPA/CPP protocol in mice [53]. We hypothesized that male, but
not female, adolescentswould display less CPA andmore CPP com-
pared toadultmale and femalemice thatwill showcomparableCPA




All experimental procedures were approved by the Florey Insti-
tute’sAnimal Ethics Committee andperformed in accordancewith
the Australian code for the care and use of animals for scientific pur-
poses. The mice came from separate breeding colonies where fe-
male andmaleDrd1a-EGFP (D1) andDrd2-EGFP (D2) hemizygous
mice were mated, all bred on an outbred Arc:Arc(S) Swiss back-
ground, established and housed in a common colony room at the
Florey Institute of Neuroscience and Mental Health, Melbourne,
Australia. Mice were originally generated by the Gene Expression
Nervous System Atlas (GENSAT) program at the Rockefeller Uni-
versity, New York, USA [43]. Only mice hemizygous for the EGFP
reporter gene were used in the study – wildtype and homozygous
littermateswere culled after genotyping atweaning. Homozygous
mice have been to showoverexpression of the tagged receptor [54]
while hemizygousmice are indistinguishable fromwildtype coun-
terparts [55]. Mice were postnatal day (P) 49±2 (referred to as
‘adolescent’ throughout this paper) or P70±4 (referred to as adult
throughout this paper) on day 1 of behavior. Mice were weaned at
P18-P21 and were housed in same-sex groups of 3-5 littermates
in open-top cages (34 cm x 16 cm x 16 cm) maintained on a 12 h
light/dark cycle (lights on at 07:00) in a temperature-controlled
(22±1.5°C) environment. Food (standard chow: Barastoc, VIC, Aus-
tralia) and water were available ad libitum.
2.2. Genotyping
Mouse pups were genotyped using PCR. DNA was extracted from
tail samples using the REDExtract-N-AMP™ Tissue PCR Kit
(Cat#: XNAT-100RXN, Sigma-Aldrich) and PCR was performed
using GoTaq®GreenMasterMix (Cat#: M7122, Promega) accord-
ing to recommended protocols. Primers were purchased from Ge-
neworks. The following forward and reverse primers were used:
• Drd1a-EGFP forward primer: 5′-ACC GGA AGT GCT TTC CTT
CTG GA-3′
• Drd1a-EGFP reverse primer: 5′-TAG CGG CTG AAG CAC TGC
A-3′
• Drd2-EGFP forward primer: 5′-GAG GAA GCA TGC CTT GAA
AA-3′
• Drd2-EGFP reverse primer: 5′-TGG TGC AGA TGA ACT TCA
GG-3′
2.3. Methamphetamine
Methamphetamine (meth)was obtained fromSigma-AldrichAus-
tralia Pty Ltd (Castle Hill, NSW, Australia; purity ³98%) and dis-
solved in 0.9% saline. The volume of intraperitoneal (i.p.) injec-
tion was 10 ml/kg. The dose of meth used in this experiment was
3 mg/kg to encourage development of conditioned place aversion
(CPA). Since we were mainly interested in whether there were dis-
tinctionsbetweensexes andages in theaversiveproperties ofmeth,
we chose a dose that was higher (and therefore likely more aver-
sive) than that used previously inmice CPP studies [51, 52, 56, 57].
In addition, pilot experimentation showed daily injections of 6-9


























Morning: all mice received saline 
Afternoon: mice received saline or meth (3 mg/kg)
Figure 1. Experiment timeline. Mice numbers (n) for meth group: adolescent male n=27, adolescent female: n=19; adult male: n=24; adult female n=19 and saline group:
adolescent male n=23, adolescent female: n=19; adult male: n=22; adult female n=18.
mg/kg ofmeth caused significantmalaise and reduced locomotion
by day 3, and therefore for ethical reasons we used 3 mg/kg that
had no observable impact on health.
2.4. Behavior
The conditioned place preference/aversion (CPP/CPA) apparatus
(Lafayette Instruments, IN, USA) consisted of two main compart-
ments with differences in visual (wall patterns) and tactile (floor
texture) cues, separated by a neutral compartment. As per a pre-
vious protocol [58], the light intensity settings were set at 30 (80
lux)within the conditioning compartments and90 (380 lux) in the
central compartment, with these values referring to the settings
on the equipment provided. These settings were chosen to deter
mice from remaining in the central compartment. The time spent
in each compartment and distance travelled as an indicator for lo-
comotor activity was recorded via horizontal optic sensor beams
and specific software for the apparatus (Motor Monitor™, Kinder
Scientific, USA). The CPP protocol and timeline (Figure 1) followed
a previously published 4-day conditioning protocol [52, 57] that is
relatively short compared to other protocols, to minimizematura-
tion during CPP. Before each session, all cages ofmice weremoved
to the experimental roomat the same time and left to habituate for
at least 30 min.
In the afternoon on day 1 (baseline), mice were placed in the
central compartment and allowed free access to all three compart-
ments. We used an unbiased approach to allocatemeth-associated
chamber. On days 2–5 (conditioning), mice received an i.p. injec-
tionof saline (10ml/kg) in themorning (08:30-11:30) andwere im-
mediately confined within one of the two conditioning chambers,
and an i.p. injection of eithermeth (3mg/kg;methgroup) or saline
(10 ml/kg; saline group) in the afternoon (12:00-15:00) and were
immediately confined into the other conditioning chamber. Tim-
ing was controlled so that each mouse had 3.5 hrs elapse between
themorning and afternoon injections. Meth was never injected in
the morning to avoid its potential influence on the afternoon ses-
sion. The afternoon injection chamber (in which animals receive
either saline or meth) was randomly allocated without an expec-
tation of CPP or CPA. The other chamber served as the morning
chamber. Once allocated, chamber designation (morning or after-
noon) never changed for the mice. An equal number of mice were
conditioned within each chamber for each group. On day 6 (test)
afternoon, mice were given free access to all three compartments
without any injections. All sessions were 30 min in duration and
occurred at the same time each day for a givenmouse.
A total of 181 mice began behavioral training. Preference for
the chamber in which they were confined during the condition-
ing afternoon sessions was calculated by dividing time spent in
that chamber by the combined time spent in both main chambers
(i.e., preference%= time in afternoon chamber / total time in both
chambers x 100). Using the samecriteria as previous research [59],
8 mice demonstrating an initial side preference > 67% at base-
line were not allocated to any group, and were eliminated from
further training. Two mice were also excluded as they had a side
preference at test > 2.75 standard deviations (SD) from their group
mean. This left 171mice that completed all testing, which gave the
final sizes of saline groups (adolescent male n=23, adolescent fe-
male: n=19; adultmale: n=22; adult female n=18) andmeth groups
(adolescentmale n=27, adolescent female: n=19; adult male: n=24;
adult female n=19). Nomore than 1mouse per group per litter was
used– that is, allmice fromeach group came fromdifferent litters.
Due to the novelty of our study examining age and sex differences
inbehavior, target group size (totalN= 144) for behaviorwas calcu-
lated using G*Power based on our repeated-measures designwith
8 groups, small to medium effect size (Cohen’s f = 0.2), type 1 & 2
error rate = 0.05 [60].
Normalized preference score at test expressed as a percentage
change frombaseline to testwas calculated by subtracting thepref-
erence score at baseline from that at test and then dividing the out-
come by the preference score at baseline (i.e., CPP % change = (%
at test - % at baseline) / % at baseline). Acquisition of CPP was
defined as change in preference > 10%, aversion was defined as
change in preference < -10%, and neutral was defined as change
in preference between 10% and -10%. These numbers were cho-
sen because 10% change appears common in previously published
studies, especially for CPA [20, 61-63].
Locomotor data were also collected throughout CPP testing to
assess the development of behavioral sensitization. It should be
noted that the sample size for CPP locomotor data does not match
that of the CPP preference data due to a technical fault, where on
certain training days (where the mice were confined to one cham-
ber) the CPP chambers stopped recording locomotion,meaning lo-
comotor data on those days were lost. Those mice were removed
completely for repeated-measures locomotion analyses that re-
quire data on all days to be present. The final locomotor sample
sizes for the saline groups were: adolescent male n=21, adolescent
female: n=17; adultmale: n=21; adult femalen=17; and for themeth
groupswere: adolescentmalen=26, adolescent female: n=17; adult
male: n=24; adult female n=16.
2.5. Tissue collection and immunohistochemistry
Following a previous learning-related c-Fos protocol in the mice
used in the present study [64], ninety min following the start of
the test session, mice were anesthetized with sodium pentobarbi-
tone (100 mg/kg, i.p.) and transcardially perfused with 50 mL 0.1
M phosphate buffered saline (PBS) immediately followed by fixa-
tion with 50 mL 4% paraformaldehyde (PFA) in phosphate buffer
(PB). Post-fixation in 4% PFA was 1 h, followed by PB washing (1
h) before being transferred into a sucrose solution (20%w/v in PB)
and stored at 4°C overnight. Brains were then snap frozen on liq-
uidnitrogen and stored at −20°C, before being sectioned into 40μm
coronal slices in a 1:4 series using a cryostat (Leica, Germany).
Fluorescent immunohistochemistry was performed to iden-
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Figure 2. Coronal sectionof themousebrain (Bregma+1.1mm) showing a typical
counted section of insular cortex [65]. Immunofluorescence-stained density of
cells positively labelled for D1 or D2 (green), c-Fos (red), and D1 or D2/c-Fos co-
labelled (green with red centre) were quantified using stereology.
tify c-Fos and EGFP tagged D1+ or D2+ cells (Figure 2). Target
group size (total N =84) were calculated using G*Power based on
between-subjects design with 16 groups (D1 vs D2 genotype is an
added factor compared to behavior), and type 1 & 2 error rate =
0.05 [60]. Medium effect size (Cohen’s f = 0.4) was chosen based
on a previous study examining c-Fos following behavior in Drd1a-
EGFP and Drd2-EGFPmice [64]. The final sample sizes were - D1
adolescents: male saline n=6; male meth n=6; female saline n=6;
female meth n=6; D1 adults: male saline n=6; male meth n=6; fe-
male saline n=6; femalemeth n=6; D2 adolescent: male saline n=6;
male meth n=6; female saline n=6; female meth n=6; D2 adults:
male saline n=4; male meth n=7; female saline n=6, female meth
n=6.
Sections were washed in PBS (3 × 5 min), and then incubated
for 30 min in a blocking solution (10% normal donkey serum
(NDS) and 0.3% Triton X-100 in PBS). Primary incubation was in
chicken anti-GFP (1 : 1000, Abcam, Cambridge, UK, Cat# ab13970,
RRID:AB_300798) and rabbit anti-c-Fos (1 : 2000, Cell Signal-
ing Technology, MA, USA, Cat# 5348, RRID:AB_10557109) in PBS
with 1% NDS and 0.3% Triton X-100 for 48 h on an orbital shaker
at 4°C. Sections were then washed in PBS (3 × 5 min) before be-
ing incubated for 30 min in a blocking solution of 10% NDS and
0.3% Triton X-100. From this point, sections were always cov-
ered in aluminum foil to prevent bleaching of fluorophores. Sec-
ondary incubation was on an orbital shaker at room temperature
for two hours in donkey anti-chicken (1 : 400, Alexa Fluor 488,
Jackson ImmunoResearchLabs, PA,USA,Cat#703-545-155, RRID:
AB_2340375) and donkey anti-rabbit (1 : 400, Alexa Fluor 594,
Jackson ImmunoResearch, Cat# 711-585-152, RRID: AB_2340621)
in PBS with 1% NDS and 0.3% Triton X-100. After washing in PBS
(3 × 5 min), sections were mounted onto slides coated in 1% gela-
tine, 0.05%chromiumpotassiumsulphate thenwere coverslipped
using fluorescent mountingmedium (Dako, CA, USA).
Table 1. Average Stereology Parameters
x-interval (μm) 247
y-interval (μm) 176
D1+ or D2+ cells counted per site 1.3
D1+ or D2+ cells counted per slice 20
D1+ or D2+ cells CE Scheaffer 0.1
2.6. Stereology
Stereology was performed using a Zeiss Axio Imager M2 (Ger-
many) microscope and Stereo Investigator software (MBF Bio-
science, VT, USA). Sections were 160 μm apart. The insular cor-
tex was quantified across ten consecutive sections (starting from
Bregma +1.70mm) from the left hemisphere to be consistent with
the previous studies using these mice [28, 64]. For each section,
the area occupied by each regionwas delineated using a 2.5 x objec-
tive lens (N.A. 0.085) according to the mouse brain atlas [65] and
cellswere counted using a 63 × objective lens (N.A. 1.4). Cell counts
were made within an unbiased counting frame of known area (30
μmx 30 μm) that was superimposed on the image of the tissue sec-
tions. The sampling grid size was determined by Stereo Investi-
gator software (MBF Bioscience) such that 20 sites were counted
in the most rostral section. Details regarding the average sam-
pling grid size (x- and y-interval), number of cells counted per
site, number of cells counted per slice, and coefficients of error (CE
Scheaffer) are listed inTable 1. The counting framewas positioned
randomly by the Stereo Investigator software, leading to a system-
atic sample of the area occupied by each region. The researcher
was blinded to the genotype, treatment, age, and sex of all samples
while counting. The estimated density of immunoreactive cells is
expressed as the number per mm3.
2.7. Data analyses
All statistical analyses were performed using IBM SPSS Statistics
23 (IBM Corp., NY, USA). Data were normally distributed. To min-
imize Type I error, behavioral (with the exception of the CPP/CPA
proportion data and correlations) and brain data were analyzed
with overall three- or four-way ANOVA with all the between sub-
jects factors included, and significant interactions were followed
up with post hoc ANOVAs with Bonferroni corrections [66]. Fac-
tors were: Age factor refers to adolescents (P49 at baseline) or
adults (P70 at baseline), Sex factor refers to male or female, Day
factor refers to baseline, conditioning day 1, 2, 3, and 4, or test,
Time factor refers to the morning (when all mice received saline)
or afternoon (when mice received either saline or meth, depend-
ing on their Group) session, Group factor refers to saline-treated
mice or meth-treated mice in the afternoon sessions, Chamber
factor refers to the morning (saline-paired) or afternoon (saline-
or meth-paired, depending on their Group) chambers, and Geno-
type factor refers to D1 or D2 expression. For behavioral data, no
effect of Genotype nor interactions involving Genotype were de-
tected, so statistics for behavioral experimentswere collapsed over
Genotype. Due to many significant two-and three-way interac-
tions, post hoc ANOVAs were necessary. When Time (morning vs
afternoon session) interacted with all other factors we did post hoc
ANOVAs examining interacting factors in the morning and after-
noon sessions separately. When Group was involved in the major-
ity of the interactions, we did post hoc ANOVAs examining the in-
teracting factors per Group. When Daywas involved inmore inter-
actions than Group, we did post hoc ANOVAs examining the inter-
acting factors in eachDay. CPP/CPA proportion datawere analyzed
using chi-square test of independence. Correlations between be-
havior and brain were assessed for significance using Pearson cor-
relational analyses.
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Figure 3. Total distance travelled (m) in the morning session following an acute saline i.p. injection and in the afternoon session following an acute saline or metham-
phetamine (meth; 3mg/kg) i.p. injection over 4 consecutive days (n=16-26 per group). Post hoc effect of Sex: (#) p < 0.05. Post hoc effect of Group on day 2 in themorning
session: (^) p < 0.05. Post hoc effect of Age only in the meth group on day 4 in the afternoon session: (*) p < 0.05. Error bars represent ± SEM.
3. Results
3.1. Locomotion
Distance travelled (i.e. locomotion) across the conditioning ses-
sions (i.e. days 2-5) were analyzed using a five-way repeatedmea-
sures (RM) analysis of variance (ANOVA) involving Time, Age,
Group, Sex, and Day factors. There were significant effects of
Time (F(1,151)=426.9, p<0.001), Day (F(3,453)=13.0, p<0.001), and
Group (F(1,151)=279.5, p<0.001; Figure 3). There were also two-
way interactions, but they all formed a part of significant three-
way interactions: Time x Age x Group (F(1,151)=5.4, p=0.021),
Time x Day x Sex (F(3,453)=3.8, p=0.01), Time x Day x Group
(F(3,453)=15.7, p<0.001), and Day x Group x Sex (F(3,453)=2.8,
p=0.04). No four- or five-way interactions were detected (small-
est p=0.14). BecauseTime interactedwithall theother factors,post
hoc ANOVAs per Time were conducted to investigate the distance
travelled in the morning sessions (when all mice received a saline
injection) or the afternoon sessions (when mice received either a
saline or meth injection depending on their Group).
A four-wayRMANOVAof themorning locomotor data revealed
a significant effect of Day (F(3,453)=85.8, p<0.001), and signifi-
cant Day x Sex (F(3,453)=3.1, p=0.027), Day xGroup (F(3,453)=11.7,
p<0.001), and Age x Sex (F(1,151)=4.0, p=0.047) interactions. No
other effects or interactions were detected (smallest p=0.22). This
Age x Sex interaction indicated that averaged across Day and
Group, adolescent females moved more than adolescent males
(F(1,79)=5.6, p=0.02); no significant sex difference was evident in
adults (F(1,76)=0.3, p=0.61). To understand the Day x Sex and Day
x Group interactions, we analyzed Sex and Group effects in each
Day, averaged across ages. These post hoc tests with Bonferroni
corrections (p value cut off: 0.05/4 days= 0.0125) revealed a Group
difference only in the second (F(1,155)=6.9, p=0.009) morning
session, with no other significant Group or Sex effects (smallest
p=0.027). In the second morning session the meth group moved
more than the saline group; that is, mice that received meth for
the first time the day before moved more after a saline injection
the next morning. Given that both groups show reduced locomo-
tion in the second morning session compared to the first morn-
ing session, our results suggest themeth group habituated slower
on the second day compared to the saline group. In summary, in
the chamber thatwas never pairedwithmeth (morning chamber),
female adolescents moved more than male adolescents and there
was a transiently delayed locomotor habituation in themeth group
compared to saline group.
Analysis of the afternoon locomotor data revealed significant
effects of Age (F(1,151)=4.6, p=0.033) and Group (F(1,151)=445.2,
p<0.001), and significant Age x Group (F(1,151)=5.0, p=0.027), Day
x Age (F(3,453)=2.9, p=0.035), and Day x Group (F(3,453)=10.1,
p<0.001) interactions; no other effects or interactions were de-
tected (smallest p=0.054). Since Group interacted with Age and
Day, post hoc tests per Group were conducted with Bonferroni cor-
rections (p value cut off: 0.05/4 days = 0.0125). Within the saline
group, there was no effect of Age in any of the afternoon sessions
(smallest p=0.30). Within the meth group there was a significant
effect of Age only in the fourth (F(1,81)=8.5, p=0.005) afternoon
session, whereby adolescents travelled further than adults. No ef-
fect was found in the other sessions (smallest p=0.02). This sug-
gests sensitization ofmeth-induced hyperlocomotionwas greater
in adolescent compared to adult mice, regardless of sex.
3.2. Conditioned place preference/aversion
A four-way RMANOVA of percentage preference for the afternoon
chamber at baseline vs test between Age, Group, and Sex revealed
a significant effect of Group (F(1,163)= 49.9; p<0.001) and a signif-
icant Day x Group interaction (F(1,163)= 7.2; p=0.008). No other
effects or interactionswere detected (smallest p=0.056). To under-
stand this Day x Group interaction, the effect of Day was assessed
in each Group. In the saline group, Day had no significant effect
(F(1,81)=0.1; p=0.72). In themethgroup, therewas a significant ef-
fect of Day (F(1,88)= 11.5; p=0.001) whereby preferencewas higher
at test compared to baseline (Figure 4a). This indicates that on av-
erage, mice treated with 3mg/kgmeth formed a preference to the
meth-paired chamber.
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Figure 4. (a) Individual conditioned place preference (CPP)% formed by saline-treated andmethamphetamine (meth)-treatedmice at test (n=18-27 per group). Preference
for the afternoon chamber was calculated by dividing time spent in that chamber by the combined time spent in both chambers (i.e., preference % = time in afternoon
chamber / time in afternoon and morning chambers x 100). Main effect of Day only in meth Group: (&) p<0.05. (b) Normalized preference score at test expressed as a
percentage change from baseline to test in meth-treated mice only (n=19-27 per group). Percentage change was calculated by subtracting the preference score at baseline
from that at test and then dividing this figure by the preference score at baseline (i.e., preference% change = (% at test -% at baseline) /% at baseline). Error bars represent
mean ± SEM. (c) Proportion of mice (n=19-27 per group) that formed a preference (preference% change > 10%), remained neutral (preference% change between 10% and
-10%), and formed an aversion (preference% change < -10%) to the meth (3 mg/kg i.p.)-paired chamber at test. Effect of Sex: (#) p < 0.05.
Based on the evidence of CPP in the meth but not saline group,
normalized preference score at test calculated as a percentage
change compared to baseline was analyzed in themeth group only
examining the effects of Age and Sex. Two-way ANOVA revealed
no main effects or an interaction (smallest p=0.60; Figure 4b),
however, we observed from normalized data that there was clear
evidence of mice that formed aversion. Therefore, we converted
this information into frequency statistics and compared groups on
the proportion ofmeth-treatedmice that formed a preference (de-
finedas change inpreference> 10%), remainedneutral (definedas
change inpreferencebetween 10%and-10%), and formedanaver-
sion (defined as change in preference < -10%) to themeth-paired
chamber using chi-square test of independence. These numbers
were chosen because 10% change is common in previously pub-
lished studies, especially for CPA [20, 61-63]. This revealed a
significant effect of Sex (χ2(2)=8.0, p=0.018) but no effect of Age
(χ2(2)=1.0, p=0.61; Figure 4c). This suggests that females aremore
likely to remain neutral compared to males after four days of con-
ditioning with 3 mg/kgmeth.
3.3. D1+ versus D2+ cell density
D1+ versus D2+ cell density in the insula were analyzed by four-
way ANOVA examining the effects of Genotype, Age, Group, and
Sex, which revealed a significant main effect of Sex (F(1,80)=19.4,
p<0.001), suggesting thatmales had a greater density of dopamine
receptor expressing cells (Figure 5a). There were significant two-
way interactions, however, they formed a part of a four-way in-
teraction of Genotype x Sex x Age x Group (F(1,80)=8.8, p=0.004).
No other main effects or interactions were detected (smallest
p=0.052). To understand this interaction, effects of Sex, Age, and
Group were analyzed per Genotype.
In the Drd1a-EGFP (D1) genotype, there was a significant in-
teraction of Sex x Age (F(1,41)=4.8, p=0.034). No other effects or
interactions were detected (smallest p=0.074). To understand the
interaction, we analyzed the effect of Age in each Sex (averaged
acrossGroup), which revealed a significant effect of Age in females
(F(1,22)=8.9, p=0.007) but not in males (p=0.50). These results
suggest female adolescents have higher insula D1+ density than
female adults, regardless of drug history.
In the Drd2a-EGFP (D2) genotype, there were significant ef-
fects ofAge (F(1,39)=8.8, p=0.005) andSex (F(1,39)=19.9, p<0.001).
There were also significant Sex x Age (F(1,39)=8.7, p=0.005) and
Sex x Age x Group (F(1,39)=5.5, p=0.024) interactions. No other
effects or interactions were detected (smallest p=0.15). To under-
stand the three-way interaction, we analyzed the effect of Age and
Group in each Sex. For males, adults had more D2+ than ado-
lescents in the meth group (F(1,11)=17.5, p=0.002) but not in the
saline group (p=0.35). There were no effects in females (small-
est p=0.080). These results suggest that meth exposure lead to
higher insula D2+ density in adults compared to adolescents in
males only.
A previous study showed that the ratio of D1+ cell density com-
pared to D2+ cell density was mediated by sex in adolescence
but not adulthood [28]. Ratio was calculated by dividing the D1+
Cullity et al. | 7



















































































































Figure5. Thedensity (cells/mm3) of (a)dopamine receptor 1 (D1)+and2 (D2)+expressingcells, (b)D1+expressingcellsnormalized to theaveragenumberofD2+expressing
cells (i.e., D1:D2 ratio), (c) c-Fos+expressingcells, and (d)D1+/c-Fos+andD2+/c-Fos+co-labelled cells in the insular cortex (insula) of saline-treatedandmethamphetamine
(meth)-treated mice (n=4-7 per group). Post hoc effect of Age: (*) p < 0.05. Error bars represent mean + SEM.
density with the average D2+ density in each group to indicate
score above 1 as D1 dominance, and below 1 as D2 dominance. A
three-way ANOVA examining the effects of Age, Group, and Sex
revealed a significant effect of Age (F(1,41)=21.0, p<0.001) and Sex
(F(1,41)=7.3, p=0.01), and a significant Age x Group x Sex interac-
tion (F(1,41)=19.7, p<0.001; Figure 5b). To understand this interac-
tion, analyses were conducted per Group.
In the saline group there was a significant effect of Age
(F(1,21)=4.6, p=0.044) and Sex (F(1,21)=5.9, p=0.024) and a signif-
icant Age x Sex interaction (F(1,21)=6.8, p=0.016). Follow-up anal-
yses were conducted per Sex, which revealed a significant effect of
Age in female (F(1,10)=12.3, p=0.006) but notmale (p=0.75) saline-
treated mice. In the meth-treated group there was a significant
effect of Age (F(1,20)=26.4, p<0.001) and a significant Age x Sex
interaction (F(1,20)=17.3, p<0.001). No effect of Sex was detected
(p=0.21). Follow-up analyses were conducted per Sex, which re-
vealed a significant effect of Age in male (F(1,10)=51.4, p<0.001)
but not female (p=0.54) meth-treated mice. This suggests that
in meth-treated males but not females, adolescents have a higher
D1:D2 ratio than adults. Conversely, in saline-treated females but
not males, adolescents have a higher D1:D2 ratio than adults.
3.4. c-Fos+ cell density
A three-way ANOVA of c-Fos+ cell density examining the effects
of Age, Group, and Sex in the insula revealed no significant effects
or interactions (smallest p=0.50; Figure 5c), suggesting that Fos
density was not affected by conditioning in any of the subjects in
this study.
3.5. D1+/c-Fos+ and D2+/c-Fos+ co-labeled cell density
A three-way ANOVA of the density of D1+/c-Fos+ co-labelled cells
in the insula examining the effects of Age, Group, and Sex revealed
no significant effects or interactions (smallest p=0.23; Figure 5d).
On the other hand, for D2+/c-Fos+ cells there was a significant ef-
fect of Group (F(1,39)=5.9, p=0.02) and a significant Age x Group
interaction (F(1,39)=5.0, p=0.031). No other effects or interactions
were detected (smallest p=0.18). Post hoc tests showed that (av-
eraged across Sex) in the saline group there was no difference in
D2+/c-Fos+ density between adolescent and adult mice (p=0.40).
In the meth group, however, adolescents had a significantly lower
D2+/c-Fos+ co-labelled density compared to adults (F(1,23)=5.2,
p=0.032). Therefore, in both sexes,meth exposure led to increased
activation of D2+ cells in adults compared to adolescents.
3.6. Correlations between preference score and the den-
sity of D1+, D2+, and c-Fos+ cells
Given the significant individual differences observed in behavior,
we further examinedpotential relationships betweenbehavior and
brain using Pearson correlational analyses separated by Age and
Group. Variables examined were % preference at baseline and
test, D1+ and D2+ cell density, c-Fos+ cell density, D1+/c-Fos+ and
D2+/c-Fos+ co-labeled cell density.
Surprisingly, saline adult group showed a significant correla-
tion (Table 2). D1+ density was positively correlated with per-
centage preference for afternoon chamber at test in adults (Fig-
ure 6). No other significant correlations were observed (small-
est p=0.59). Further, no significant correlations were observed in
meth-treated adult and adolescent mice (smallest p=0.058; Table
4 & Table 5).
4. Discussion
The present study showed that whilemice overall formed a prefer-
ence for a chamber paired with 3 mg/kgmeth, females were more
likely to remain neutral compared to males. No age differences
were observed. Conditioning with meth led to age differences in
insula D1:D2 ratio for males while reducing age differences in fe-
males, and increased c-Fos labeling in insula D2 expressing cells
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Table 2. Pearson Correlation r values between behavior and brain in adult saline-treated mice.







r(8)=0.041, p=0.911 r(8)=-0.316, p=0.373




r(11)=0.500, p=0.082 r(8)=0.109, p=0.764 r(8)=-0.614,
p=0.059
(*) p < 0.025 (Bonferroni corrected).
Table 3. Pearson Correlation r values between behavior and brain in adolescent saline-treated mice.
c-Fos+ D1+ density D1+/c-Fos+ density D2+ density D2+/c-Fos+ density




r(10)=0.339, p=0.281 r(10)=0.118, p=0.715




Table 4. Pearson Correlation r values between behavior and brain in adult meth-treated mice.















Table 5. Pearson Correlation r values between behavior and brain in adolescent meth-treated mice.









r(10)=0.133, p=0.681 r(10)=0.287, p=0.365






r(10)=0.450, p=0.142 r(10)=0.451, p=0.141
in adults compared to adolescents. Insula activity and expression
of D1 and D2 were not correlated to test behavior following condi-
tioning with meth.
4.1. Meth-induced locomotion, but not conditionedplace
behavior, is age-dependent
Contrary to our hypothesis, adolescents were not less likely to
form CPA (or more likely to form CPP) to 3 mg/kg meth com-
pared to adults. This is consistent with the report that adoles-
cent and adult male rats show similar acquisition of meth self-
administrationwhen given 2 h per day access [67], althoughwhen
access is increased from 2 to 6 h sessions, adolescent male rats
self-administer significantly more meth compared to adults [68].
Our results suggest that such age effect during extended access of
meth self-administration may not be driven by adolescents find-
ingmeth less aversive compared to adults.
Rather, age differences were observed in locomotion in the
present study, with adolescents displaying enhanced sensitization
of meth-induced hyperlocomotion compared to adults. This con-
trasts with finding that male adults display enhanced hyperloco-
motion relative to adolescents induced by 0.5 mg/kg of meth in
rats [69]. Inmalemice, adultsmovedmore than adolescentswhen
acutely injected with 2 mg/kg, but not 4 mg/kg of meth [70]. The
age effect in our studywas observed in the last day of conditioning,
suggesting that adolescents showed sensitization whereas adults
did not. Adolescents may be less sensitive to the stimulant effects
of low doses but more sensitive to high doses of meth, especially
with repeated injections.
4.2. Sex differences in meth CPP/CPA
While both sexes displayed similar meth CPP at a group level, ex-
amination of individual differences revealed that females were
more likely to remain neutral compared to males. This is the first
data being analyzed on individual changes in meth CPP. The lack
of sex differences at the group level agrees with previous research
that examined awide range ofmeth doses (0.1-5.6mg/kg) in adult
rats, although large variability was reported [63].
4.3. Insula andmeth exposure
Conditioning with meth induced an age difference in males such
that D1:D2 ratio was higher in adolescents relative to adults,
whereas it abolished the higher D1:D2 ratio seen in female adoles-
cents relative to adults in the insula. Meth also led to enhanced ac-
tivation of D2 expressing cells in adults compared to adolescents.
These results suggest insula D2 expression in adulthood changes
with meth exposure, though it is not necessarily correlated with
the formation of meth-induced CPP. Insula D1 and D2 expression
maybemore susceptible to changes in adulthood compared to ado-
lescence. It has been shown previously that the number of D2,
c-Fos, and c-Fos co-labeled D1 and D2 cells in the prelimbic cor-
tex and infralimbic cortex are altered cumulativelywith increasing
stimulation in adult mice [64].
In our previous study using naïve mice, male adolescents had
a substantially lower D1:D2 ratio compared to adults, whereas fe-
male adolescents and adults had a similar D1:D2 ratio [28]. The
present study was more invasive in comparison (i.e. daily han-
dling, confinement to chambers, injections). This appears to have
Cullity et al. | 9



















Figure 6. The density (cells/mm3) of dopamine receptor 1 expressing cells insular
significantly correlate with afternoon chamber % preference only in adult saline
rats (r = 0.671).
reduced D1:D2 ratio in adults compared to Cullity et al. (2019), be-
cause in saline mice we found adolescent and adult males had a
similar D1:D2 ratio, whereas adolescent females had higher D1:D2
ratio compared to adults (Figure 5b). Notably, the discrepant re-
sults between the present saline mice and naïve mice from Cul-
lity et al. (2019) may also be a result of the age at perfusion. In
this study, mice were P54 and P75 when perfused; in our previous
study, mice were P49 and P70 when perfused [28]. Future studies
examining D1 and D2 expression in naïve P54 and P75mice would
clarify this potential explanation.
4.4. Insula and place conditioning with meth
Despite the significant changes in the insula induced by meth ex-
posure, these changes were not associated with test behavior at
group or individual level. For example, the density of c-Fos cells
(co-labelled or not) was unrelated to behavior at baseline or test
(Tables 2-5), confirming that insula cells are not recruited during
the expression of CPP or CPA.
Surprisingly, insula D1 density in saline conditioned adultswas
positively correlated to their preference for their afternoon cham-
ber at test. Of note, insula D1 density was not associated with
the baseline preference, indicating that these effects did not re-
sult from their reaction to a novel environment. These data sug-
gest that over numerous days of exposure to distinct environ-
ments without any other manipulation, mice may show a non-
associative preference that is related to expression of insula D1 in
adulthood. When mice were conditioned with meth, these rela-
tions were no longer observed. Too few CPP/CPA studies include
and/or report between-subjects saline-saline place preference in
relation to insular or other brain regions to be able tomeaningfully
interpret this finding. Our results highlight the need ofmore stud-
ies to include saline-saline controls to discriminate between asso-
ciative andnon-associative place preference thatmicemay display.
The individual data plots suggest that group interpretationmay be
misleading in any CPP/CPA studies.
4.5. Limitations and future directions
We referred to mid-late adolescent mice as ‘adolescents’ through-
out this study. While these mice were perfused well before the
stabilization of hormones that occur in young adulthood (P60) in
mice [47], an age effect may have been observed if younger mice
were used.
A single high dose of meth was used in the present study. This
dose (3 mg/kg) was the highest dose identified in a pilot experi-
ment to not cause any malaise in these mice. As such, outcomes
maybe differentwith lower doses. Studies utilizing0.125-2mg/kg
of meth have consistently observed CPP [51, 52, 57, 69, 71], and
showed that 0.125-2 mg/kg of meth induces similar CPP in male
adolescent and adult mice and rats [51, 69]. It has been shown in
rats that adolescent males form a preference more quickly than
adults at 0.5 and 1 mg/kg of meth [69]. Notably, all those previ-
ous studies have been in males only and potential sex- and age-
differences at lower doses of meth remains unexplored. Addition-
ally, more studies should assess individual differences, consider-
ing the variability that are often observed in CPP/CPA studies.
Changes in D1 and D2 expression did not appear to be associ-
atedwithplace conditioningwith 3mg/kgmeth. This is consistent
with recent meta-analyses showing that dopamine receptor gene
polymorphisms may not determine risk towards meth use disor-
der [72]. Nevertheless, conditioning with meth altered insula D1
andD2expression,whichmaysubserve changes inbehaviors com-
monly observed followingmeth use. For example, social cognition
impairments inmeth users have been shown to be associatedwith
insula hypoactivity [73, 74], which would be interesting to estab-
lish in mice to target for testing potential therapeutics. Further,
protein inhibition of insula after CPP recall or extinction has been
shown to prevent CPP expression for upto 24 days [42]. Thus, age-
and sex-specific assessment of insula’s role in CPP/CPA following
extinction appears warranted considering extinction deficits reli-
ably observed in adolescent rodents and humans [75-80].
Lastly, with known involvement of D1 and D2 signaling in CPP
andCPA[38, 39], other regions that showage-andsex-differences
in D1 and D2 expression should be explored. The present results
showing sex but not age differences inmeth-induced CPP are con-
sistent with females showing D1 dominance compared tomales in
the dorsal and ventral striatumregardless of age [28],which impli-
cates areas such as the nucleus accumbens in driving CPP and/or
CPA.
5. Conclusion
The present study demonstrates that males are more likely to ex-
perience a high dose of meth as rewarding or aversive compared
to females. Age differences in vulnerability to meth use are poten-
tially not driven by differences in how aversive they experience a
high dose of meth. Preference or aversion expressed at test does
not appear to be related to insula activity or D1 and D2 expression.
Interestingly, we have shown that adults may be more susceptible
to change in insula D1 and D2 expression followingmeth exposure
compared to adolescents. D1 and D2 are considered importantme-
diators of adolescent vulnerability to substanceuse [77, 81-83]. Fu-
ture experiments should assess sex and age differences in the role
of insula in behaviors affected by chronic meth use, such as social
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